Johnson & Johnson pens Alzheimer’s gene therapy pact – FierceBiotech
FierceBiotech |
Johnson & Johnson pens Alzheimer's gene therapy pact
FierceBiotech The workaround being pursued by J&J is underpinned by AAV research performed by Jim Wilson, M.D., Ph.D. and others at the university's gene therapy program. Wilson and his collaborators have been working to improve AAVs for more than two decades … |
